biognosis limited
biognosis limited Company Information
Company Number
03312825
Website
www.biognosisltd.co.ukRegistered Address
chantry house 22 upperton road, eastbourne, east sussex, BN21 1BF
Industry
Other personal service activities n.e.c.
Telephone
-
Next Accounts Due
November 2025
Group Structure
View All
Shareholders
elaine rachel garvican 55%
john harry garvican 44.5%
View Allbiognosis limited Estimated Valuation
Pomanda estimates the enterprise value of BIOGNOSIS LIMITED at £93.3k based on a Turnover of £125.5k and 0.74x industry multiple (adjusted for size and gross margin).
biognosis limited Estimated Valuation
Pomanda estimates the enterprise value of BIOGNOSIS LIMITED at £0 based on an EBITDA of £-713 and a 6.08x industry multiple (adjusted for size and gross margin).
biognosis limited Estimated Valuation
Pomanda estimates the enterprise value of BIOGNOSIS LIMITED at £191.3k based on Net Assets of £70.9k and 2.7x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Biognosis Limited Overview
Biognosis Limited is a live company located in east sussex, BN21 1BF with a Companies House number of 03312825. It operates in the other service activities n.e.c. sector, SIC Code 96090. Founded in February 1997, it's largest shareholder is elaine rachel garvican with a 55% stake. Biognosis Limited is a mature, micro sized company, Pomanda has estimated its turnover at £125.5k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Biognosis Limited Health Check
Pomanda's financial health check has awarded Biognosis Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 7 areas for improvement. Company Health Check FAQs
1 Strong
2 Regular
7 Weak
Size
annual sales of £125.5k, make it smaller than the average company (£594.4k)
- Biognosis Limited
£594.4k - Industry AVG
Growth
3 year (CAGR) sales growth of -15%, show it is growing at a slower rate (7%)
- Biognosis Limited
7% - Industry AVG
Production
with a gross margin of 36.6%, this company has a comparable cost of product (36.6%)
- Biognosis Limited
36.6% - Industry AVG
Profitability
an operating margin of -0.9% make it less profitable than the average company (6%)
- Biognosis Limited
6% - Industry AVG
Employees
with 1 employees, this is below the industry average (13)
1 - Biognosis Limited
13 - Industry AVG
Pay Structure
on an average salary of £25.6k, the company has an equivalent pay structure (£25.6k)
- Biognosis Limited
£25.6k - Industry AVG
Efficiency
resulting in sales per employee of £125.5k, this is more efficient (£55k)
- Biognosis Limited
£55k - Industry AVG
Debtor Days
it gets paid by customers after 36 days, this is later than average (24 days)
- Biognosis Limited
24 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Biognosis Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Biognosis Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 17 weeks, this is less cash available to meet short term requirements (82 weeks)
17 weeks - Biognosis Limited
82 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 39.8%, this is a higher level of debt than the average (32.3%)
39.8% - Biognosis Limited
32.3% - Industry AVG
BIOGNOSIS LIMITED financials
Biognosis Limited's latest turnover from February 2024 is estimated at £125.5 thousand and the company has net assets of £70.9 thousand. According to their latest financial statements, Biognosis Limited has 1 employee and maintains cash reserves of £16 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 | Feb 2016 | Feb 2015 | Feb 2014 | Feb 2013 | Feb 2012 | Feb 2011 | Feb 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | |||||||||||||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | |||||||||||||||
| Tax | |||||||||||||||
| Profit After Tax | |||||||||||||||
| Dividends Paid | |||||||||||||||
| Retained Profit | |||||||||||||||
| Employee Costs | |||||||||||||||
| Number Of Employees | 1 | 1 | 3 | 3 | 3 | 3 | 3 | 3 | 1 | ||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 | Feb 2016 | Feb 2015 | Feb 2014 | Feb 2013 | Feb 2012 | Feb 2011 | Feb 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 1,446 | 1,496 | 1,993 | 2,657 | 2,508 | 2,440 | 3,253 | 4,338 | 4,863 | 3,933 | 3,596 | 3,971 | 4,171 | 3,042 | 4,056 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 87,975 | 73,114 | 63,394 | 59,165 | 49,964 | 49,045 | 20,000 | 20,000 | 0 | 0 | 0 | 0 | 2,188 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 1,446 | 1,496 | 89,968 | 75,771 | 65,902 | 61,605 | 53,217 | 53,383 | 24,863 | 23,933 | 3,596 | 3,971 | 4,171 | 3,042 | 6,244 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 900 | 0 | 0 | 0 | 0 | 240 | 3,000 | 4,585 | 3,270 |
| Trade Debtors | 12,693 | 18,728 | 8,671 | 16,501 | 10,264 | 11,569 | 3,732 | 30,451 | 12,795 | 41,869 | 37,559 | 38,575 | 40,686 | 26,731 | 45,270 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 87,447 | 87,462 | 8,679 | 4,176 | 6,312 | 7,633 | 9,230 | 8,485 | 13,926 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 16,027 | 19,929 | 13,492 | 20,262 | 25,330 | 30,856 | 35,421 | 48,048 | 81,842 | 74,440 | 100,977 | 106,559 | 105,107 | 109,078 | 91,163 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 116,167 | 126,119 | 30,842 | 40,939 | 41,906 | 50,058 | 49,283 | 86,984 | 108,563 | 116,309 | 138,536 | 145,374 | 148,793 | 140,394 | 139,703 |
| total assets | 117,613 | 127,615 | 120,810 | 116,710 | 107,808 | 111,663 | 102,500 | 140,367 | 133,426 | 140,242 | 142,132 | 149,345 | 152,964 | 143,436 | 145,947 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35,552 | 42,534 | 53,302 | 72,861 | 85,793 | 74,416 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 46,477 | 56,172 | 49,604 | 49,938 | 43,839 | 40,791 | 35,556 | 29,010 | 27,329 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 46,477 | 56,172 | 49,604 | 49,938 | 43,839 | 40,791 | 35,556 | 29,010 | 27,329 | 35,552 | 42,534 | 53,302 | 72,861 | 85,793 | 74,416 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 275 | 284 | 7,530 | 5,357 | 4,032 | 4,234 | 2,486 | 2,578 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 275 | 284 | 7,530 | 5,357 | 4,032 | 4,234 | 2,486 | 2,578 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 46,752 | 56,456 | 57,134 | 55,295 | 47,871 | 45,025 | 38,042 | 31,588 | 27,329 | 35,552 | 42,534 | 53,302 | 72,861 | 85,793 | 74,416 |
| net assets | 70,861 | 71,159 | 63,676 | 61,415 | 59,937 | 66,638 | 64,458 | 108,779 | 106,097 | 104,690 | 99,598 | 96,043 | 80,103 | 57,643 | 71,531 |
| total shareholders funds | 70,861 | 71,159 | 63,676 | 61,415 | 59,937 | 66,638 | 64,458 | 108,779 | 106,097 | 104,690 | 99,598 | 96,043 | 80,103 | 57,643 | 71,531 |
| Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 | Feb 2016 | Feb 2015 | Feb 2014 | Feb 2013 | Feb 2012 | Feb 2011 | Feb 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | 483 | 497 | 664 | 886 | 836 | 813 | 1,085 | 1,446 | 1,622 | 1,311 | 1,198 | 1,324 | 1,390 | 1,014 | 1,353 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | |||||||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | -900 | 900 | 0 | 0 | 0 | -240 | -2,760 | -1,585 | 1,315 | 3,270 |
| Debtors | -6,050 | 88,840 | -3,327 | 4,101 | -2,626 | 6,240 | -25,974 | 12,215 | -15,148 | 4,310 | -1,016 | -2,111 | 13,955 | -18,539 | 45,270 |
| Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -35,552 | -6,982 | -10,768 | -19,559 | -12,932 | 11,377 | 74,416 |
| Accruals and Deferred Income | -9,695 | 6,568 | -334 | 6,099 | 3,048 | 5,235 | 6,546 | 1,681 | 27,329 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | -9 | -7,246 | 2,173 | 1,325 | -202 | 1,748 | -92 | 2,578 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | 0 | -87,975 | 14,861 | 9,720 | 4,229 | 9,201 | 919 | 29,045 | 0 | 20,000 | 0 | 0 | 0 | -2,188 | 2,188 |
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||||||
| interest | |||||||||||||||
| cash flow from financing | |||||||||||||||
| cash and cash equivalents | |||||||||||||||
| cash | -3,902 | 6,437 | -6,770 | -5,068 | -5,526 | -4,565 | -12,627 | -33,794 | 7,402 | -26,537 | -5,582 | 1,452 | -3,971 | 17,915 | 91,163 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -3,902 | 6,437 | -6,770 | -5,068 | -5,526 | -4,565 | -12,627 | -33,794 | 7,402 | -26,537 | -5,582 | 1,452 | -3,971 | 17,915 | 91,163 |
biognosis limited Credit Report and Business Information
Biognosis Limited Competitor Analysis
Perform a competitor analysis for biognosis limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
biognosis limited Ownership
BIOGNOSIS LIMITED group structure
Biognosis Limited has no subsidiary companies.
Ultimate parent company
BIOGNOSIS LIMITED
03312825
biognosis limited directors
Biognosis Limited currently has 3 directors. The longest serving directors include Dr John Garvican (Feb 1997) and Dr Linda Garvican (Feb 1997).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr John Garvican | England | 75 years | Feb 1997 | - | Director |
| Dr Linda Garvican | 74 years | Feb 1997 | - | Director | |
| Dr Elaine Garvican | United Kingdom | 44 years | May 2010 | - | Director |
P&L
February 2024turnover
125.5k
-20%
operating profit
-1.2k
0%
gross margin
36.6%
-10.43%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
February 2024net assets
70.9k
0%
total assets
117.6k
-0.08%
cash
16k
-0.2%
net assets
Total assets minus all liabilities
Similar Companies
biognosis limited company details
company number
03312825
Type
Private limited with Share Capital
industry
96090 - Other personal service activities n.e.c.
incorporation date
February 1997
age
27
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
incorporated
UK
address
chantry house 22 upperton road, eastbourne, east sussex, BN21 1BF
last accounts submitted
February 2024
biognosis limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to biognosis limited.
biognosis limited Companies House Filings - See Documents
| date | description | view/download |
|---|
